XPRO America: End-to-End US FDA Drug Entity Registration & Product Listing Through FDA CDER Direct Portal

Introduction: Why FDA Drug Compliance Is a Business-Critical Requirement

Entering or continuing in the United States pharmaceutical market requires more than product quality—it demands strict regulatory compliance with the US FDA. Any company involved in manufacturing, repackaging, relabeling, private labeling, or distributing drugs for U.S. commercial distribution must complete Drug Establishment Registration and Drug Product Listing through the official FDA CDER Direct Portal.

This is where XPRO America positions itself as a trusted US FDA consulting and US FDA Agent partner, delivering end-to-end regulatory services for drug companies worldwide. From entity registration to Structured Product Labeling (SPL) and post-submission lifecycle management, XPRO America ensures your compliance is accurate, timely, and commercially aligned.


Understanding the FDA CDER Direct Portal

https://fdaatty.com/wp-content/uploads/2018/01/CDER-Direct.jpg
https://www.freyrsolutions.com/sites/default/files/images/blog-images/an-overview-of-establishment-registration-with-the-us-fda-infographic.png
https://www.fdahelp.us/images/ndc.png

4

The FDA CDER Direct Portal is the official electronic submission system managed by the Center for Drug Evaluation and Research, a division of the U.S. Food and Drug Administration.

It is mandatory for:

  • Drug manufacturers (domestic & foreign)
  • Private label distributors
  • Generic drug facilities
  • Outsourcing facilities (503B)
  • Contract manufacturers and packagers

Through CDER Direct, companies submit regulatory data that legally authorizes their drugs to remain in U.S. commercial distribution.


What Is US FDA Drug Establishment Registration?

Drug Establishment Registration is a mandatory annual requirement under the Federal Food, Drug, and Cosmetic Act. Any facility involved in drug-related activities must:

  • Register the physical establishment with FDA
  • Renew registration every year
  • Update changes in ownership, location, or operations

XPRO America manages initial registrations, renewals, and amendments, ensuring zero disruption to business operations.


Drug Product Listing & Structured Product Labeling (SPL)

https://fdalisting.com/wp-content/uploads/2025/08/fda-drug-registration-certificate.webp

4

What Is Drug Product Listing?

Drug Listing is the FDA’s method of linking specific drug products to registered establishments. Each listed drug must include:

  • Proprietary and non-proprietary names
  • Dosage form and route of administration
  • Strength and formulation
  • Packaging configurations
  • Manufacturing and labeling roles

Why SPL Is Critical

The FDA only accepts drug listings in Structured Product Labeling (SPL) format—an XML-based technical standard, not a PDF or Word document.

XPRO America provides:

  • SPL authoring and XML structuring
  • FDA schema validation
  • Error-free CDER Direct uploads
  • Ongoing SPL lifecycle updates

This technical expertise significantly reduces FDA rejection risk.


NDC Labeler Code & Product Code Support

A valid National Drug Code (NDC) is required for drugs marketed in the U.S.

Through CDER Direct, XPRO America supports:

  • NDC Labeler Code requests
  • NDC product and package code reservations
  • Corrections and updates

This ensures your products are commercially launch-ready and aligned with distributor and retailer requirements.


XPRO America as Your Official US FDA Agent

https://www.meddevicecorp.com/wp-content/uploads/2023/10/US-FDA-Agent-Services.jpg
https://www.propublica.org/wp-content/uploads/2023/04/202304-FDA-Overseas.JPG

4

For non-U.S. drug manufacturers, appointing a US FDA Agent is mandatory.

XPRO America Provides:

  • Official US FDA Agent appointment
  • FDA correspondence handling
  • Inspection and compliance communication support
  • Emergency and regulatory notice coordination

This role is critical during:

  • FDA inspections
  • Compliance queries
  • Import alerts or clarifications

End-to-End US FDA Drug Compliance Services by XPRO America

XPRO America delivers a complete regulatory ecosystem, including:

  • Drug Establishment Registration (Initial & Annual Renewal)
  • Drug Product Listing via SPL
  • NDC Labeler Code applications
  • CDER Direct portal submissions
  • SPL amendments and maintenance
  • US FDA Agent services
  • Regulatory consulting and guidance

Clients benefit from single-window accountability, eliminating the need for multiple vendors.


Advantages of Choosing XPRO America for FDA CDER Direct Compliance

1. Direct Portal Expertise (Not Theoretical Consulting)

XPRO America works hands-on inside FDA CDER Direct, ensuring submissions meet FDA’s live validation standards.

2. Zero-Error, First-Time-Right Submissions

FDA rejections delay launches and damage credibility. XPRO America follows a precision-driven compliance model.

3. Global Client Support

Serving U.S. and international companies, including exporters targeting the U.S. market.

4. Lifecycle Compliance Management

From onboarding to annual renewals and post-approval changes, compliance is continuously managed.

5. Faster Commercial Readiness

Accurate FDA registration and listing enables:

  • Distributor onboarding
  • Amazon/Walmart seller approvals
  • Import clearance readiness

Complimentary American Business A-I-R-S Number Certificate (Lead Magnet)

https://images.we-saas.com/insecure/fill/500/0/ce/0/plain/https%3A//nium-r2.we-saas.com/uploads/2037ac50-fea0-4eea-ad12-2e186a93addb/1734013625117-certificate-of-good-standing-missouri-us-7faa2eb8bcbbdc8dd130.jpg%40webp
https://unitedstatesbusinessregistration.us/wp-content/uploads/al_opt_content/IMAGE/unitedstatesbusinessregistration.us/wp-content/uploads/2024/05/federal-small-business.jpg.bv_resized_mobile.jpg.bv.webp?bv_host=unitedstatesbusinessregistration.us

4

As a value-added benefit, XPRO America provides a complimentary American Business A-I-R-S Number Certificateto new clients.

Why This Matters:

  • Enhances business credibility
  • Supports investor and partner due diligence
  • Useful for international companies entering the U.S. ecosystem
  • Strengthens trust with distributors and procurement teams

This certificate acts as a commercial credibility booster, making it a powerful lead magnet for new FDA compliance clients.


Who Should Work With XPRO America?

XPRO America is ideal for:

  • Drug manufacturers (innovator & generic)
  • Private label pharmaceutical brands
  • Contract manufacturing organizations (CMOs)
  • Foreign exporters targeting the U.S. drug market
  • Startups preparing for U.S. commercialization

Compliance Is Not a Cost—It’s a Revenue Enabler

Without valid FDA registrations and listings:

  • Products can be detained at U.S. ports
  • Commercial distributors may reject onboarding
  • Regulatory non-compliance risks enforcement actions

XPRO America ensures your regulatory foundation supports growth, trust, and revenue, not bottlenecks.


Conclusion: Partner With XPRO America for FDA CDER Direct Success

Navigating US FDA Drug Entity Registration and Product Listing through the FDA CDER Direct Portal requires technical accuracy, regulatory insight, and real-world execution.

XPRO America delivers:

  • End-to-end FDA drug compliance
  • Official US FDA Agent services
  • Expert SPL and CDER Direct submissions
  • Complimentary American Business A-I-R-S Number Certificate

For companies serious about long-term U.S. market success, XPRO America is not just a consultant—it is a strategic FDA compliance partner.